Navigation Links
Discovery Labs Reports Fourth Quarter 2012 Financial Results
Date:3/13/2013

be able to agree on the matters raised during regulatory reviews, or Discovery Labs may be required to conduct significant additional activities to potentially gain approval of its product candidates, if ever, (b) the FDA or other regulatory authorities may not accept or may withhold or delay consideration of any of Discovery Labs' applications, or may not approve or may limit approval of Discovery Labs' products to particular indications or impose unanticipated label limitations, and (c) changes in the national or international political and regulatory environment may make it more difficult to gain FDA or other regulatory approval; Discovery Labs may be unable to develop and manufacture drug products, AFECTAIR® aerosol-conducting airway connectors and capillary aerosol generator (CAG) devices for clinical studies, and, if approved, for commercialization of drug and combination drug-device products and, if cleared for marketing, medical device products, including risks of technology transfers to contract manufacturers and problems or delays encountered by Discovery Labs, its contract manufacturers or suppliers in manufacturing drug products, drug substances and other materials and aerosol-conducting airway connectors and CAG devices on a timely basis or in an amount sufficient to support Discovery Labs' development efforts and, if approved, commercialization; Discovery Labs research and development activities may involve (i) time-consuming and expensive pre-clinical studies, clinical trials and other efforts, which may be subject to potentially significant delays or regulatory holds, or fail, and (ii) the need for sophisticated and extensive analytical methodologies; Discovery Labs or its strategic partners or collaborators will not be able to retain, or attract, qualified personnel; Discovery Labs may be unable to maintain compliance with The Nasdaq Capital Market listing requirements; Discovery Labs
'/>"/>

SOURCE Discovery Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. E-Discovery Industry Veteran Joins VeDISCOVERY LLC
2. Innovative Research Collaboration to Advance Next-Generation Methods in Peptide Discovery for Cosmeceuticals
3. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
4. PrimerLife.com, a Skolkovo Participant Company, Celebrates Anniversary of DNA Discovery with Launch of New Social Network
5. RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds
6. Emerald Logic announces collaboration with Kings College London on quantitative biomarker discovery
7. Drug Discovery and Development Market in Asia - Partnerships Between MNCs and Asian Academic Institutions and Healthcare Research Organizations are Driving R&D Innovation
8. Harrington Discovery Institute at University Hospitals Case Medical Center Announces Grant Funding to Physician-Scientists at Major Academic Medical Centers to Support New Drug Development
9. GDS International Announces "Industry Leader of the Year" Award at its Fourth Annual European Pharmaceutical Drug Discovery Summit
10. Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
11. Rochester Medical Corporation to Participate in The Benchmark Company, LLC Micro Cap Discovery Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  According to the American Optometric ... spend on digital devices. An AOA survey reports that ... and 17 estimate they use an electronic device for ... AOA survey of parents revealed that only 40 percent ... for that same amount of time. Eye doctors are ...
(Date:7/22/2014)... July 22, 2014  Vernalis plc (LSE: VER) and Tris ... (POC) for CCP-08, the third programme to achieve ... collaboration. Under this collaboration, POC requires the successful ... pilot comparative study against an immediate release reference ... will make a milestone payment to Tris. ...
(Date:7/22/2014)... , July 22, 2014 /PRNewswire/ ... für umfassenden Schutz von Pharmazeuten und ...    Equashield ( http://www.equashield.com ... (Closed System Transfer Devices, CSTDs) für gefährliche Medikamente, ... Vertriebshändler und Hersteller von medizinischen Produkten, zu ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... PARK, Calif., Sept. 14 Praxis EMR has submitted its ... EMRs to apply for HITECH certification in the country. Under ... in federal incentives if they can demonstrate "meaningful use" of ... the U.S. Department of Health and Human Services to test ...
... Reportlinker.com announces that a new market research ... Autistic Disorder - Pipeline Assessment and Market ... Autistic Disorder - Pipeline ... SummaryGlobalData, the industry analysis specialist, has released ...
Cached Medicine Technology:Praxis EMR Among First to Apply for HITECH Certification 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 3
(Date:7/23/2014)... Picnic Lunches, Residents of The Clare can now enjoy the ... still dining on the fabulous cuisine of Chef Hagop Hagopian. ... to the beach or museum and we love to make ... said Brian Hughes, director of dining services for The Clare. ... , Hagopian, the executive chef of The Clare is trained ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Print ... Print Audit Facilities Manager web portal. Facilities Manager ... releases of the software as well as numerous ... , Print Audit Facilities Manager is a powerful, ... to remotely collect meter reads, automate supplies fulfillment ...
(Date:7/22/2014)... July 22, 2014 As one alternative ... consumers to buy can now reduce or in some ... has released its cosmetic buying guide to help buyers ... http://cherrynews.com/best-nourishing-eye-serum . , This guide is meant for ... the different under eye circles that can appear. While ...
(Date:7/22/2014)... 2014 The market for beauty products ... through 2022, according to new industry reports. Women who ... benefit from a new guide published at the Cherry ... now available at http://cherrynews.com/best-nourishing-eye-serum . , This published ... to many of the top skin improvement products on ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Dr. Jeremy ... his surgical colleagues, have recently discussed the reasons for ... leaders in the periodontics profession are seeing the amount ... up exponentially. In fact, one surgeon reported that over ... implants. Although dental implants have a very high success ...
Breaking Medicine News(10 mins):Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Eye Serum Review for Women: New Guide Published Online by Top Review Website 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3
... safe and well-tolerated for elderly patients with chronic lymphocytic ... their disease, researchers from The University of Texas M. ... annual meeting of the American Society of Hematology. , ... of activity against CLL in our phase II clinical ...
... Deaconess Hospital has entered an agreement with Omaha-based ... Medicare-eligible patients access to an expanded lineup of Medicare ... Patients who elect coverage through Deaconess can now ... including Mutual of Omaha, UnitedHealthcare, Coventry, CIGNA, Aetna, Pyramid ...
... to Start Exploring Their Shared Genetics , ... Mountain View, CA (PRWEB) ... personal genetics, today announced it is offering a Multiple Kit discount ... in a single order will save $200 on the first three kits ...
... The end of fall marks an exciting time,for ... their,professional careers. Fellows from around the world will gather ... Interventions (SCAI),Third Annual Interventional Cardiology Fall Fellows Course in ... Given the aging population and the increasing number ...
... to blame; experts cite risk of skin cancer , , ... states to restrict and limit indoor tanning by children ... a worrisome trend, because ultraviolet radiation, whether from the ... skin cancer, the most common malignancy in the United ...
... Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today ... lorcaserin, its novel drug candidate for the treatment ... Obesity, the official peer reviewed journal,of The Obesity ... with lorcaserin, as compared to placebo, experienced,statistically significant ...
Cached Medicine News:Health News:Lenalidomide safe as single therapy for elderly CLL patients 2Health News:Deaconess Hospital Partners With Senior Market Sales to Expand Insurance Offering for Medicare-Eligible Patients 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 2Health News:23andMe Announces Holiday Season Multi-Pack Discount 3Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 2Health News:SCAI's Annual Fall Fellows Course Prepares New Interventional Cardiologists to Work in the Field 3Health News:Laws Governing Indoor Tanning by Teens Don't Work 2Health News:Laws Governing Indoor Tanning by Teens Don't Work 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 2Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 3Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 4Health News:Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity 5
... the typical patient, right for the not-so-typical ... you have the ability to address the ... least expect themeven after implant. St. Jude ... to be prepared in almost any situation, ...
... The R4Mplus offers global companies a ... meet RFID compliance initiatives. With die-cast ... variety of connectivity options, and complex ... a super value. Plus, the fully ...
... combines enhanced memory, processing capacity, ... reliable all-metal construction. Proven platform ... print speed make it the ... value reliability, productivity, consistent print ...
... companies a cost-effective and dependable performer ... With die-cast metal construction, centralized printer/encoder ... and complex multi-language font support, the ... the fully integrated RFID reader/encoder supports ...
Medicine Products: